State-of-the-art in the management of chronic myelogenous leukemia in the era of the tyrosine kinase inhibitors: Evolutionary trends in diagnosis, monitoring and treatment

Alvaro Aguayo; Stephen Couban

doi:10.3109/10428190903370387

State-of-the-art in the management of chronic myelogenous leukemia in the era of the tyrosine kinase inhibitors: Evolutionary trends in diagnosis, monitoring and treatment

Alvaro Aguayo, Stephen Couban

Pharmacology, Toxicology and Pharmaceutics

Research output: Contribution to journal › Review article › peer-review

13 Citations (Scopus)

Original language	English
Pages (from-to)	1-8
Number of pages	8
Journal	Leukemia and Lymphoma
Volume	50
Issue number	SUPPL. 2
DOIs	https://doi.org/10.3109/10428190903370387
Publication status	Published - 2009

ASJC Scopus Subject Areas

Hematology
Oncology
Cancer Research

Keywords

Chronic myelogenous leukemia
Imatinib
Therapy
Tyrosine kinase inhibitors

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.3109/10428190903370387

Cite this

@article{b209803c4e2044909637133dca0c7bf2,

title = "State-of-the-art in the management of chronic myelogenous leukemia in the era of the tyrosine kinase inhibitors: Evolutionary trends in diagnosis, monitoring and treatment",

keywords = "Chronic myelogenous leukemia, Imatinib, Therapy, Tyrosine kinase inhibitors",

author = "Alvaro Aguayo and Stephen Couban",

year = "2009",

doi = "10.3109/10428190903370387",

language = "English",

volume = "50",

pages = "1--8",

journal = "Leukemia and Lymphoma",

issn = "1042-8194",

publisher = "Informa Healthcare",

number = "SUPPL. 2",

}

TY - JOUR

T1 - State-of-the-art in the management of chronic myelogenous leukemia in the era of the tyrosine kinase inhibitors

T2 - Evolutionary trends in diagnosis, monitoring and treatment

AU - Aguayo, Alvaro

AU - Couban, Stephen

PY - 2009

Y1 - 2009

KW - Chronic myelogenous leukemia

KW - Imatinib

KW - Therapy

KW - Tyrosine kinase inhibitors

UR - http://www.scopus.com/inward/record.url?scp=73849126019&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=73849126019&partnerID=8YFLogxK

U2 - 10.3109/10428190903370387

DO - 10.3109/10428190903370387

M3 - Review article

C2 - 20017605

AN - SCOPUS:73849126019

SN - 1042-8194

VL - 50

SP - 1

EP - 8

JO - Leukemia and Lymphoma

JF - Leukemia and Lymphoma

IS - SUPPL. 2

ER -

State-of-the-art in the management of chronic myelogenous leukemia in the era of the tyrosine kinase inhibitors: Evolutionary trends in diagnosis, monitoring and treatment

ASJC Scopus Subject Areas

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this